Simulated microgravity accelerates alpha-synuclein aggregation and induces oxidative stress in an in vitro Parkinson disease model
Veronica LentiniiD, Giuseppe UrasiD, Alessia MancaiD, Mohammed Amine El FaqiriD, Sara Lucas Del PozoiD, Nicola Deiana, Giacomo CaoiD, Anthony H.V. SchapiraiD, Antonella PantaleoiD
Abstract
Parkinsons disease (PD) is a neurodegenerative disorder characterized by the accumulation of alpha-synuclein aggregates and progressive neuronal loss in the substantia nigra, with aging being its primary risk factor. The current available models to study PD mechanisms are largely relying on genetic mutations to recapitulate PD typical hallmarks, such as increased alpha-synuclein aggregation. However, they do not model the aging features associated with the disease. Microgravity, a condition experience by astronauts during space missions, is known to induce ageing-like modifications on both systemic and cellular physiology. To replicate the aging-related stress observed in PD patients, we exposed SH-SY5Y and 3K-SNCA mutant cell lines to simulated microgravity. Our findings revealed that simulated microgravity enhanced PD alterations, with a significant increase in misfolded and phosphorylated a-syn. This was accompanied by heightened oxidative stress, as evidenced by increased levels of reactive oxygen species, without a sufficient antioxidant response. These results suggest that simulated microgravity effectively mimics and accelerate the stress associated with aging in PD cell models, regardless of the presence of PD mutation. This study highlights the potential of simulated microgravity as a tool for investigating aging processes in neurodegenerative diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Spaceflight-relevant microgravity triggers a sublethal Parkinson's-like dopaminergic decline in human neurons and organoids.
Nilufar Ali, Shehbeel Arif, … Julia Thom Oxford·bioRxiv·Jul 15, 2026
- Overexpression of human alpha-synuclein leads to dysregulated microbiome and metabolites with ageing in a rat model of Parkinson disease
Yogesh Singh, Christoph Trautwein, … Nicolas Casadei·Molecular NeurodegenerationPeer-reviewed·Jul 4, 2023
- Bradykinesia and postural instability in a model of prodromal Synucleinopathy with alpha-Synuclein aggregation in the gigantocellular nuclei.
Vasileios Theologidis, Sara Almeida Ferreira, … Asad Jan·bioRxiv·Sep 5, 2024
- Combination of alpha-synuclein aggregation inhibitor anle138b and ER stress inhibitor AMG PERK 44 increases neuroprotection in Parkinson's disease organoid model
Natalia Siwecka, Michał Golberg, … Ireneusz Majsterek·bioRxiv·Mar 18, 2026
- Molecular aging is the main driver of Parkinson's Disease
Verena Bopp, Jaehyun LeeBae, … Karin M. Danzer·bioRxiv·Aug 27, 2025
- Alpha-synuclein overexpression can drive microbiome dysbiosis in mice
Timothy R. Sampson, Zachary D Wallen, … Ashley S. Harms·bioRxiv·Feb 1, 2024